Abcam

Abcam

A producer and distributor of research-grade antibodies and associated products.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*

$5.7b

Valuation: $5.7b

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
GBP2017201820192020202120222023
Revenues0000000000000000000000000000
% growth21 %14 %7 %2 %15 %21 %17 %
EBITDA0000000000000000000000000000
% EBITDA margin33 %38 %28 %26 %15 %12 %32 %
Profit0000000000000000000000000000
% profit margin20 %27 %17 %5 %5 %(2 %)15 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue9 %5 %6 %7 %6 %16 %-

Source: Company filings or news article, Equity research estimates

More about Abcam
Made with AI
Edit

Abcam is a biotechnology company that specializes in the supply of antibodies and reagents, which are essential tools for scientific research and diagnostics. The company operates in the life sciences market, catering primarily to academic researchers, pharmaceutical companies, and diagnostic laboratories. Abcam's product range includes primary and secondary antibodies, biochemicals, cell and tissue imaging tools, and various kits and assays used in research areas such as cancer, cardiovascular diseases, cell biology, immunology, and neuroscience.

Abcam's business model is centered around providing high-quality, reliable products that help scientists achieve accurate and reproducible results in their experiments. The company offers a vast catalog of products, which can be easily searched and purchased through their website. Additionally, Abcam provides customized products and commercial partnerships to accelerate diagnostic and therapeutic programs, offering tailored solutions to meet specific research needs.

Revenue is generated through the direct sale of these products to researchers and institutions. The company also engages in partnerships and collaborations, which can include co-development agreements and licensing deals, further diversifying its income streams. Abcam's commitment to customer support and product quality has established it as a trusted supplier in the scientific community.

Keywords: antibodies, reagents, biotechnology, life sciences, diagnostics, research tools, customized products, partnerships, scientific research, pharmaceutical.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Abcam

Edit
Firefly BioWorks
ACQUISITION by Abcam Jan 2015
AxioMx
ACQUISITION by Abcam Nov 2015
Epitomics
ACQUISITION by Abcam Mar 2012
MitoSciences
ACQUISITION by Abcam May 2011
Expedeon
ACQUISITION by Abcam Nov 2019
Ascent Scientific
ACQUISITION by Abcam Sep 2011
Calico Biolabs
ACQUISITION by Abcam Jan 2019
BioVision
ACQUISITION by Abcam Aug 2021